Metformin Co-Supplementation Protocol
When taking metformin, Chandel recommends co-supplementing with B12 and citrulline to offset known metformin-induced deficiencies, and using a CGM to verify the drug is actually blunting postprandial glucose spikes.
Assembled by Cited from Navdeep Chandel's recorded recommendations across multiple sources. It is not an ordered program and was not created or endorsed by them — it's our grouping of what they've said on the record.
Components
4-
Organic (prompted) In a protocol
Chandel considers metformin before meals to blunt postprandial glucose spikes in pre-diabetic or insulin-resistant people; weak case for insulin-sensitive individuals.
“metformin abrogates that [glucose spike]... 30 minutes before a meal
TP▶ 1:46:17DosageTake ~30 minutes before mealsCaveatsCan cause B12 deficiency and lower citrulline; may blunt exercise-induced VO2max/hypertrophy gainsCertaintyhedgedrecommendationMetformin ~30 min before meals for pre-diabetic/insulin-resistant people -
In a protocol
Chandel recommends B12 supplementation for those on metformin because metformin reduces B12 absorption in the gut.
“B12 levels go down with metformin. So people should take B12
TP▶ 1:02:44CertaintyexplicitrecommendationB12 to offset metformin-induced B12 deficiency -
Organic (prompted) In a protocol
Chandel suggests citrulline supplementation for those on metformin, since metformin lowers blood citrulline, potentially impairing vasodilation and exercise response.
“if you're taking metformin, take citrulline
TP▶ 1:02:01CaveatsMechanism via NO/vasodilation is speculativeCertaintyhedgedrecommendationCitrulline to offset metformin-induced citrulline drop and preserve vasodilation/exercise response -
In a protocol
Chandel suggests using a CGM during a metformin trial to see if postprandial glucose spikes are being blunted.
“You have a glucose monitor or you do it for three months
TP▶ 1:05:20DosageUse for ~3 months to assess metformin's effect on glucose spikesCertaintyhedgedrecommendationCGM for ~3 months to verify metformin is blunting postprandial glucose spikes
How this protocol has evolved
Chandel is more bullish on metformin than he was 7-8 years ago, now seeing mechanistic rationale for glucose lowering, inflammation reduction (pollution, CHIP), and potential niche cancer uses.